TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

3

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

3

ST13

US500000090717366

Class

42

Filing

90717366

Registration

6896720

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

12/25/2024

Classification

Registered

Trademark type

Combined

Nice classes

42

Filing date

05/18/2021

Registration date

11/08/2022

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/08/2022

Last transaction

12/25/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2022-04-00

First use in commerce

2022-04-00

Drawing code

3

Owner type

16

Owner location

Fort Myers, FL, US

Examiner

KETCHUM, BRENDAN J

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a two dimensional cube where three of the intersecting sides are formed by the representation of a monoclonal antibody and the number 3 appearing on the right side of the two dimensional cube.

Holders and representatives

Holders

Baysient, LLC

Representatives

Mark A. Nieds Coherence Legal, PLLC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Providing temporary use of on-line non-downloadable software and applications for use in determining time required for a patient to receive optimal pharmaceutical benefit levels based on analysis of pharmaceutical dosage data and patient data

Publications

History of USPTO decisions and trademark events.

23 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/21/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/21/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/21/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/01/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/01/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/01/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/08/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

11/08/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/05/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/04/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/02/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/02/2022

IUAF

USE AMENDMENT FILED

08/19/2022

EISU

TEAS STATEMENT OF USE RECEIVED

08/19/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/03/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/08/2022

PUBO

PUBLISHED FOR OPPOSITION

03/08/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/16/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/01/2022

DOCK

ASSIGNED TO EXAMINER

01/27/2022

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/17/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/16/2021

NWAP

NEW APPLICATION ENTERED

05/21/2021

Continuous trademark protection

Get notified about every new filing that threatens 3 or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.